Christopher Nardo

Christopher Nardo

Corporate Officer/Principal at DERMATA THERAPEUTICS, INC.

Net worth: 585 $ as of 30/04/2024

59 year
Health Technology
Consumer Services

Profile

Christopher J.
Nardo
is currently the Chief Development Officer & Senior VP at Dermata Therapeutics, Inc. He previously worked as the Senior Director-Clinical Development at Allergan, Inc. from 2010 to 2015 and as the Vice President-Clinical Operations & Biostatistics at Spectrum Pharmaceuticals, Inc. from 2005 to 2010.
Dr. Nardo holds a graduate degree from San Diego State University, an undergraduate degree from Loyola Marymount University, and a doctorate degree from The University of North Carolina at Chapel Hill.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
20/03/2024 1,722 ( 0.03% ) 585 $ 30/04/2024

Christopher Nardo active positions

CompaniesPositionStart
DERMATA THERAPEUTICS, INC. Corporate Officer/Principal 01/06/2015
All active positions of Christopher Nardo

Former positions of Christopher Nardo

CompaniesPositionEnd
ALLERGAN, INC. Corporate Officer/Principal 01/01/2015
SPECTRUM PHARMACEUTICALS, INC. Corporate Officer/Principal 01/01/2010
See the detail of Christopher Nardo's experience

Training of Christopher Nardo

The University of North Carolina at Chapel Hill Doctorate Degree
Loyola Marymount University Undergraduate Degree
San Diego State University Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christopher Nardo's experience

Connections

73

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
DERMATA THERAPEUTICS, INC.

Health Technology

SPECTRUM PHARMACEUTICALS, INC.

Health Technology

Private companies1

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Christopher Nardo